antibiotics is one of 272 small molecule programs targeting Erythema. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
206 competitors in Lung Cancer
Keytruda
Opdivo
Tagrisso
Beyfortus
Abraxane
Alunbrig
Ilaris
Verzenio
Tyvyt
Hycamtin
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details